Molecules/OCRELIZUMAB

OCRELIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2017

Mechanism of action: B-lymphocyte antigen CD20 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

2H7OcrelizumabOCRELIZUMABOCRELIZUMAB COMPONENT OF OCREVUS ZUNOVOOCRELIZUMAB-OCSQOCREVUSPR-070769PR070769R-1594RG-1594

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to OCRELIZUMAB

Loading drug network...